The weekly litigation news digest is live. Subscribe now

IP Verse

Cross-Linked Hydrogels For Soft Tissue Augmentation - EP3520827

The patent EP3520827 was granted to Allergan on May 25, 2022. The application was originally filed on Mar 21, 2011 under application number EP19157683A. The patent is currently recorded with a legal status of "Revoked".

EP3520827

ALLERGAN
Application Number
EP19157683A
Filing Date
Mar 21, 2011
Status
Revoked
Aug 25, 2023
Publication Date
May 25, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERZ AESTHETICSFeb 14, 2023JACOBIADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006194758
OPPOSITIONUS2009263447
OPPOSITIONUS9044477
OPPOSITIONWO0046252
OPPOSITIONWO0230990
OPPOSITIONWO2005113608
OPPOSITIONWO2006015490
OPPOSITIONWO2008143816
OPPOSITIONWO2009026158
OPPOSITIONWO2010053918
OPPOSITIONWO2011119468
SEARCHUS2009263447
SEARCHWO2005113608
SEARCHWO2008143816
SEARCHWO2009026158

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents